Diabetes mellitus

DM Type I & II: 1 The Pathophysiology of Diabetes Mellitus Diabetes mellitus (DM) is a condition in the body that is related to a faulty metabolism. It means that the body’s metabolism is not functioning properly, which leads to adverse effects in the health. The food we ingest, gets broken down into blood sugar (glucose), which is what fuels our body in the form of energy. This converted glucose needs to enter our cells so that it can be used for energy and growth. And in order for the glucose

Gestational Diabetes Mellitus (GDM) is defined as glucose intolerance that occurs during pregnancy [1]. GDM is a widespread condition in Indian women during pregnancy affecting nearly 21 percent of all pregnancies [2, 3] nationwide. Prevalence of GDM in India differs from region to region, with 3.8% in Kashmir [4], 16.55% in Tamil Nadu [5], 7.7% in Maharashtra, 7.1% in Haryana [6], 19% in National Capital Region [3]. Epidemiological studies have confirmed the association of GDM with increased feto-maternal

Diabetes mellitus is an autoimmune dysfunction characterized by hyperglycemia resulting from lack of insulin, lack of insulin resistance, or both with the involvement of destruction of cells known as beta cells, which produce insulin in the organ called pancreas. The pathophysiology behind this metabolic disorder is that there are two types of diabetes mellitus, Type 1 and Type 2 and are two very distinct entities. For those who predispose to Type 1 diabetes, a triggering event, possibly a viral

Evaristo Vazquez MED 2056, VNFT29 Diabetes Mellitus Michela Leytam 12/08/14 Pathophysiology All types of diabetes are related to a deficiency in the hormone insulin, which is secreted by the beta cells os the pancreas. In a healthy person, insulin is produced in response to elevated levels of glucose in the bloodstream and its major role is to control glucose concentration in the blood by letting the glucose enter our cells and lowering its levels. What insulin does is allowing the body

Diabetes Mellitus “Diabetes mellitus (DM) is a chronic multisystem disease related to abnormal insulin production, impaired insulin utilization, or both” (Lazear, 2014, p. 1153). The two most common types of diabetes mellitus are known as type 1 and type 2. Type 1 has been previously referred to as “juvenile-onset diabetes” or “insulin-dependent diabetes” (Lazear, 2014). Even though type 1 can occur at any age, the primary age group is younger than 30 years old (Smeltzer, Bare, Hinkle, & Cheever

symptoms and test results were Type 1 and Type 2 Diabetes Mellitus and Hypothyroidism. The elevated A1C, glucose and insulin levels pointed to one of the two types of diabetes. The normal thyroid panel results helped us to rule out Hypothyroidism, which we originally thought could be the problem because of her matching symptoms of remarkable fatigue, weight gain and dry skin. The dry skin, weight gain, and recent fatigue also pointed to Diabetes, along with her other key symptoms, blurred vision

Integrative Pathophysiology of Diabetes Narelle Fleming 30095474 Diabetes mellitus caused by lack of insulin production and/or insulin resistance can cause a variety of symptoms. Insulin resistance is a condition where insulin is produced by the body (Insulin Resistance and Prediabetes), but the body’s cells become resistant to insulin (Stoppler, 2014). In insulin resistance, glucose builds up in the blood, when normally it is absorbed by the body’s cells, where it is converted to energy, which

Introduction Diabetes mellitus is a chronic disorder characterized by complete or partial insulin deficiency and/or cellular resistance to the actions of insulin which results in an accumulation of glucose in the blood leading to hyperglycemia. Several classifications of medications can be utilized to manage elevated blood glucose in patients with diabetes mellitus. Many formulations of insulin are available to manage blood glucose levels with variations in onset, peak, and duration. Insulin’s mechanism

AM Drug consult request: Does canagliflozin compared to glimepiride provide an efficient and safe add-on therapy to metformin for uncontrolled type 2 diabetic patients? Background Type 2 Diabetes Mellitus (T2DM) is a lifelong progressive disease with increasing prevelence.1,2 It is the most common form of diabetes (90-95% of diabetic patients) and requires continuous medical care.1,2 For most T2DM patients, metformin is considered the first line of pharmacological treatment in addition to proper diet

Gestational diabetes mellitus (GDM) is a type of diabetes that occurs during pregnancy and caused by insulin resistance in the body. Risk factors of GDM include maternal age, ethnicity, family history, BMI, and deficiency of vitamin D. To be diagnosed with GDM, a woman must go through two screenings tests called the glucose challenge test and glucose tolerance test with high blood glucose results. Proper management such as a healthy diet, physical activity, and medications are needed to prevent